Sanara MedTech Inc SMTI
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Are SMTI, LAB, ATKR, VAL Obtaining Fair Deals for their Shareholders?
-
Sanara MedTech Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sanara MedTech Inc. - SMTI
-
SMTI Stock Alert: Halper Sadeh LLC is Investigating Whether Sanara MedTech Inc. is Obtaining a Fair Price for its Shareholders
-
Sanara MedTech Inc. Reports Second Quarter 2026 Financial Results (Unaudited)
-
Are MKTX, SMTI, FBRX, LXFR Obtaining Fair Deals for their Shareholders?
-
$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger—FBRX, LXFR, SMTI, and MKTX
-
Are MKTX, SMTI, LPSN Obtaining Fair Deals for their Shareholders?
-
Sanara MedTech Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sanara MedTech Inc. - SMTI
Trading Information
- Previous Close Price
- $35.12
- Day Range
- $35.08–35.52
- 52-Week Range
- $16.05–35.52
- Bid/Ask
- $14.04 / $55.79
- Shares Outstanding
- 9.19M
- Market Cap
- $322.41M
- Volume/Avg
- 164,762 / 280,139
Key Statistics
- Price/Earnings (Normalized)
- 44.99
- Price/Sales
- 2.78
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Growth
- Total Number of Employees
- 108
- Website
- https://www.sanaramedtech.com
Valuation
|
Metric
|
SMTI
|
|---|---|
Price/Earnings (Normalized) | 44.99 |
Price/Book Value | 40.67 |
Price/Sales | 2.78 |
Price/Cash Flow | 33.70 |
Price/Earnings
SMTI
Financial Strength
|
Metric
|
SMTI
|
|---|---|
Quick Ratio | 2.24 |
Current Ratio | 2.58 |
Interest Coverage | 0.95 |
Quick Ratio
SMTI
Profitability
|
Metric
|
SMTI
|
|---|---|
Return on Assets (Normalized) | 8.99% |
Return on Equity (Normalized) | 54.85% |
Return on Invested Capital (Normalized) | 23.38% |
Return on Assets
SMTI
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| LOCK|GSC!Tn^n | LOCK|br% | $151B | |||
| Becton Dickinson & Co
BDX
| LOCK|#!P | LOCK|h&b< | $53B | |||
| ResMed Inc
RMD
| LOCK|#cR%<CFP | LOCK|!rp# | $34B | |||
| Medline Inc Ordinary Shares - Class A
MDLN
| LOCK|&gB&#>s | LOCK|^$S?D | $32B | |||
| Alcon Inc
ALC
| LOCK|fwNpgw | LOCK|T^>M! | $32B | |||
| West Pharmaceutical Services Inc
WST
| LOCK|v$Q%##?^ | LOCK|sq | $27B | |||
| Solventum Corp
SOLV
| LOCK|D!xf%Pk | LOCK|xn? | $15B | |||
| Baxter International Inc
BAX
| LOCK|#&m | LOCK|%?HB | $13B | |||
| Repligen Corp
RGEN
| LOCK|JG^^<!pf | LOCK|$#^@v | $12B | |||
| The Cooper Companies Inc
COO
| LOCK|m!hY@@ | LOCK|?%c>! | $11B |
United States